8 December 2021 - Haemophilia, brain disorders and malaria are being targeted.

Public interest in medical research has lately been dominated by treatments and vaccines for COVID-19. But research in other areas has continued, and is about to bear fruit. 

In 2022 giant strides will be made in treating haemophilia, and there will be a resurgence of interest in drugs for neurological disorders—and progress on malaria.

Read The Economist article